Remove companies takeda-pharmaceutical-co-ltd
article thumbnail

Myovant Sciences Announces Corporate Updates and Financial Results for Second Fiscal Quarter 2022

Benzinga

On October 23, 2022, Sumitovant Biopharma Ltd. Sumitovant), in conjunction with parent company Sumitomo Pharma Co., billion on a fully diluted basis, and a total company value of $2.9 In October 2022, Myovant's commercialization partner, Accord Healthcare, Ltd. Sumitovant Biopharma Ltd.,